Best Agrolife Ltd

Best Agrolife Ltd

₹ 16.0 -1.24%
08 Jun - close price
About

Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.

It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]

Key Points

Business Overview
The company is the 13th Largest Indian Agrochemical Company, with a portfolio of 525+ formulations and 123+ technical manufacturing licenses. It offers a wide range of herbicides, insecticides, fungicides, and plant growth regulators including Ronfen, Citigen, Tricolor, Azaro, Cubax Power, etc. [1] [2] [3]

  • Market Cap 566 Cr.
  • Current Price 16.0
  • High / Low 35.8 / 12.3
  • Stock P/E 63.8
  • Book Value 21.7
  • Dividend Yield 1.25 %
  • ROCE 5.16 %
  • ROE 1.16 %
  • Face Value 1.00

Pros

  • Stock is trading at 0.74 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 6.78% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 9.01% over last 3 years.
  • Dividend payout has been low at 5.61% of profits over last 3 years
  • Debtor days have increased from 115 to 142 days.
  • Working capital days have increased from 70.0 days to 103 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
254 612 811 314 135 519 747 274 274 381 517 203 156
247 482 667 296 202 465 600 280 270 335 439 199 183
Operating Profit 7 130 144 19 -67 55 147 -6 4 46 78 4 -27
OPM % 3% 21% 18% 6% -50% 11% 20% -2% 2% 12% 15% 2% -17%
1 4 -3 1 1 3 1 -0 1 4 -2 1 1
Interest 13 12 15 19 15 16 16 16 17 14 13 15 12
Depreciation 7 7 8 6 11 10 10 11 12 10 10 10 10
Profit before tax -12 115 118 -6 -92 32 121 -33 -24 26 52 -20 -48
Tax % -28% 21% 19% 3% -22% 33% 22% -26% -9% 22% 26% -36% -23%
-8 90 95 -7 -72 21 95 -24 -22 20 39 -13 -37
EPS in Rs -0.24 2.55 2.67 -0.19 -2.04 0.60 2.67 -0.68 -0.62 0.56 1.10 -0.36 -1.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
127 151 905 1,211 1,746 1,873 1,814 1,257
126 154 854 1,045 1,432 1,648 1,614 1,157
Operating Profit 1 -2 51 166 314 226 200 100
OPM % 0% -1% 6% 14% 18% 12% 11% 8%
1 4 7 2 3 3 5 5
Interest 1 2 5 15 39 62 66 53
Depreciation 0 0 3 12 24 33 43 42
Profit before tax 0 0 51 141 253 134 96 10
Tax % 575% 100% 27% 26% 24% 21% 27% 10%
-0 0 37 105 192 106 70 9
EPS in Rs -0.04 0.00 1.12 2.95 5.41 2.99 1.97 0.25
Dividend Payout % 0% 798% 12% 5% 4% 7% 10% 0%
Compounded Sales Growth
10 Years: %
5 Years: 7%
3 Years: -10%
TTM: -31%
Compounded Profit Growth
10 Years: %
5 Years: -25%
3 Years: -64%
TTM: -87%
Stock Price CAGR
10 Years: 28%
5 Years: -4%
3 Years: -39%
1 Year: -28%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 9%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8 8 22 24 24 24 24 35
Reserves 46 48 108 306 504 623 734 733
0 19 33 270 568 637 478 442
63 35 209 384 380 729 713 475
Total Liabilities 117 110 372 984 1,475 2,013 1,949 1,686
0 0 19 180 203 362 374 351
CWIP 0 0 4 5 14 15 1 1
Investments 32 3 0 0 0 0 1 1
85 107 349 800 1,258 1,636 1,573 1,333
Total Assets 117 110 372 984 1,475 2,013 1,949 1,686

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-14 -41 13 -60 -180 36 228 97
-34 31 8 -15 -19 -63 -29 1
48 10 -11 67 248 -1 -199 -96
Net Cash Flow 0 -0 10 -8 49 -29 -0 2
Free Cash Flow -14 -42 6 -66 -218 -10 208 91
CFO/OP -2,460% 1,884% 48% -13% -32% 33% 123% 117%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 85 87 53 77 73 91 113 142
Inventory Days 67 199 391 864 577 271
Days Payable 72 124 167 521 404 133
Cash Conversion Cycle 85 87 48 152 297 434 286 281
Working Capital Days 60 150 33 52 47 43 64 103
ROCE % 0% 41% 34% 16% 13% 5%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Distributors
Count

Log in to view insights

Please log in to see hidden values.

Login
Total Headcount (Employees)
Count
Formulations Manufacturing Capacity
MTPA/KL
Formulations Registrations (India)
Count
Technicals Manufacturing Capacity
MTPA

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.44% 50.44% 50.44% 50.44% 50.44%
10.84% 9.86% 8.86% 8.77% 8.73% 8.03% 5.11% 5.80% 5.75% 5.75% 5.63% 5.53%
2.55% 2.63% 2.53% 2.53% 2.53% 2.67% 2.74% 2.74% 2.74% 2.11% 2.11% 2.11%
36.50% 37.42% 38.50% 38.60% 38.62% 39.18% 42.06% 41.01% 41.05% 41.70% 41.82% 41.94%
No. of Shareholders 27,20031,94037,57139,86141,57040,57337,66637,49436,63037,18138,18068,254

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls